Product Name: 4-(methylamino)-3-nitrobenzoic acid CAS 41263-74-5
Benzoic acid, 4-(methylamino)-3-nitro-;
Chemical & Physical Properties:
Appearance : Yellow solid
Boiling Point:393.7℃ at 760 mmHg
Melting Point: >300℃
4-(methylamino)-3-nitrobenzoic acid is used to Dabigatran Etexilate Mesylate intermediate.
Dabigatran etexilate is another new type of oral anticoagulant drug approved by the US Food and Drug Administration after warfarin. It is a non-peptide thrombin inhibitor that specifically and selectively blocks thrombin. (Free type or combined type) activity to exert anticoagulant effect. It has the characteristics of oral administration, potency, no need for special medication monitoring, and few drug interactions. It is a major progress in the field of anticoagulant therapy and the prevention of potentially fatal thrombosis, and has a milestone significance.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.